期刊文献+

水通道蛋白4和基质金属蛋白酶-9水平预测脑梗死患者发生恶性脑梗死的价值 被引量:5

Value of aquaporin 4 and matrix metalloproteinase-9 levels in predicting malignant cerebral infarction in patients with cerebral infarction
原文传递
导出
摘要 目的探讨血清水通道蛋白4(AQP4)和基质金属蛋白酶-9(MMP-9)水平预测脑梗死患者发生恶性脑梗死的价值。方法选取大脑半球大面积脑梗死患者66例,收集临床资料,根据临床症状及脑CT检查结果将患者分为恶性脑梗死(MCI)组和非MCI组,检测入院第1、4、7天血清AQP4和MMP-9水平,利用受试者工作特征曲线(ROC)分析血清AQP4和MMP-9水平预测发生MCI的价值。结果MCI组患者在第4天抽取的血样中,AQP4和MMP-9水平均高于非MCI组患者,差异均有统计学意义(P<0.05)。同时在MCI组患者中,第4天血清AQP4、MMP-9水平明显高于第1天及第7天水平,差异均有统计学意义(P<0.05)。在非MCI组患者中,AQP4、MMP-9三个时间点前后测量比较差异无统计学意义(P>0.05)。ROC曲线分析显示,血清AQP4水平预测发生MCI的曲线下面积为0.654(95%CI:0.516~0.792),当血清AQP4=23.49μg/L时,灵敏度为0.57,特异度为0.74。结论MCI患者血清AQP4和MMP-9水平升高,联合检测血清AQP4和MMP-9有助于早期鉴别诊断MCI。 Objective To investigate the diagnostic value of serum levels of aquaporin-4(AQP4 and matrix metalloproteinase-9(MMP-9)in predicting malignant cerebral infarction in patients with cerebral infarction.Methods The clinical data about 66 patients with hemisphere massive cerebral infarction were collected.According to clinical symptoms and brain computed tomography(CT)findings,the patients were divided into malignant cerebral infarction group(MCI)and non-MCI group.The serum levels of AQP4 and MMP-9 were detected 1,4,7 days.The diagnostic value of AQP4 and MMP-9 in predicting occurrence of MCI was analysed by receiver operating characteristic(ROC)curve.Results The serum levels of AQP4 and MMP-9 in MCI group were significantly higher than those in non-MCI group in the fourth day(P<0.05).In MCI group,AQP4 and MMP-9 in the fourth day were significant higher than other two time points(P<0.05).But in non-MCI group,AQP4 and MMP-9 in different time points have no differences(P>0.05).ROC curve analysis showed that the aera under curve for the serum levels of AQP4 was 0.654(95%CI:0.516-0.792).When the serum AQP4=23.49μg/L,the sensitivity and specificity were0.57,0.74,respectively.Conclusions Serum AQP4 and MMP-9 levels were increased in patients with MCI.Combined detection of serum AQP4 and MMP-9 is helpful for early differential diagnosis of MCI.
作者 王梅蕾 秦琳 华键 查蕾蕾 韩杨 周其达 Wang Meilei;Qin Lin;Hua Jian;Cha Leilei;Han Yang;Zhou Qida(Department of Neurology,Xishan People's Hospital,Wuxi 214101,China)
出处 《中国医师杂志》 CAS 2019年第10期1473-1476,共4页 Journal of Chinese Physician
基金 江苏省无锡市卫生计生委科研资助项目(ME201501)~~
关键词 水通道蛋白质4 基质金属蛋白酶9 脑梗死 预测 Aquaporin 4 Matrix metalloproteinase 9 Brain infarction Forecasting
  • 相关文献

参考文献6

二级参考文献48

  • 1吕恒顺.β-七叶皂甙钠及其临床应用[J].同济医科大学学报,1993,22(3):218-218. 被引量:93
  • 2范学军,郭科,肖波,资晓宏,宋治.七叶皂甙钠对局灶性脑缺血再灌注损伤大鼠Bcl-2和Caspase-3表达及细胞凋亡的影响[J].中南大学学报(医学版),2005,30(3):261-265. 被引量:15
  • 3Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 4Frank JI, Schumm LP, Wroblewski K, et al. Hemicraniectomy anddurotomy upon deterioration from infarction-related swelling trial randomized pilot clinical trial[J]. Stroke, 2014, 45(3): 781-787.
  • 5Hamade YJ, Zammar SG, E1 Tecle NE, et al. Hemicraniectomy for acute stroke in patients older than age 60: Neurosurgeons on the frontlines of multidisciplinary sU'oke therapy[J]. World Neurosurg, 2014, 82(6): 931-932.
  • 6Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (decimal trial)[J]. Stroke, 2007, 38(9): 2506-2517.
  • 7Back L, Nagaraja V, Kapur A, et al. Role of decompressive hemicraniectomy in extensive middle cerebral artery strokes: a meta-analysis of randomised trials [J]. Intern Med J, 2015, 45 (7): 711-717.
  • 8Juttler E, Schwab S, Schmiedek P, et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial[J]. Stroke, 2007, 38(9): 2518-2525.
  • 9Juttler E, Unterberg A, Woitzik J, et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke [J]. N Engl J Med, 2014, 370(12): 1091-1100.
  • 10Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial[J]. Lancet Neurol, 2009, 8(4): 326-333.

共引文献1278

同被引文献44

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部